AI 기반 집단건강관리 시장 : 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the AI in population health management market size is expected to increase from USD 13.67 billion in 2025 to USD 16.76 billion in 2026 and reach USD 46.51 billion by 2031, growing at a CAGR of 22.64% over 2026-2031.

This report is Segmented by Component (Software and Services), Deployment Mode (Cloud-Based, On-Premises, and Hybrid), Application (Population Health Analytics, Patient Engagement, Risk Stratification, and More), End User (Healthcare Providers, Healthcare Payers, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market and Forecasted in Terms of Value (USD).

Global AI In Population Health Management Market Trends and Insights

Shift Toward Value-Based Reimbursement

The AI in population health management market is gaining direct support from payment reform because value-based care now creates an operating need for continuous performance measurement rather than a discretionary analytics project. TEAM is active in 2026 as a mandatory bundled payment model in selected geographies. That change moves value-based accountability from an optional program into a daily requirement for many provider organizations. This matters because mandatory models reach health systems that had stayed outside earlier pilots, including organizations that were slower to fund analytics, workflow automation, or care management tools. The AI in the population health management market, therefore, benefits from a broader demand base, since providers now need better forecasting, attribution management, and utilization control to protect margins under risk-based contracts. ACO REACH savings of USD 930 per beneficiary also make the return on better population oversight easier to defend in capital planning and board discussions. As specialty-focused value-based models move closer to wider use from 2027 onward, population-level AI will increasingly function as a revenue protection tool as much as a clinical support layer.

Rising Chronic-Disease Burden

The AI in the population health management market is also expanding because chronic disease is creating a larger and more complex base of patients who need continuous monitoring, prioritization, and intervention over the years, rather than isolated visits. Global diabetes prevalence reached 588.7 million in 2024, and that burden is being compounded by cardiovascular disease, obesity, and multimorbidity across many health systems. In China, chronic diseases accounted for more than 80% of deaths and over 70% of total disease burden, while prevalence among people aged 60 and above reached 81.1%. These conditions are pushing the AI in the population health management market toward models that can combine long time horizons, multiple conditions, and care patterns that span providers and settings. They are also making single-institution datasets less sufficient, which supports the shift toward federated learning and multi-institution data collaboration for chronic disease modeling. In primary care Medicaid settings, proactive AI-enabled chronic disease management programs reported 22.9% fewer all-cause acute events and 48.3% fewer ambulatory care-sensitive hospitalizations, which strengthens the case for payer-side and provider-side investment in AI in the population health management market.

Unclear AI Reimbursement and Liability Frameworks

The AI in the population health management market still faces a meaningful brake because reimbursement policy has not fully caught up with software-led clinical support and population-level decision systems. Health Affairs noted in 2026 that Medicare payment methodology was not built for software-based AI services, which leaves many tools squeezed into older benefit categories and creates uncertain payment treatment. When buyers cannot see a stable reimbursement path, they become more selective about deploying tools that improve outcomes but may not generate a direct and near-term billing mechanism. That hesitation affects contracting, implementation speed, and internal ownership because finance teams, legal teams, and clinical leaders often judge the same product through different risk lenses. The AI in population health management market is especially exposed, where vendors are asking providers to fund tools that may reduce future utilization, even when the long-term clinical value is strong. Until policy gives clearer signals on reimbursement treatment and responsibility for AI-assisted decisions, adoption will continue to move faster in administrative and operational use cases than in tools that sit closer to formal benefit design or medical necessity decisions.

Other drivers and restraints analyzed in the detailed report include:

1. AI-Driven Risk Stratification and Care-Gap Closure
2. Primary-Care Workforce Shortages Favor Panel Automation
3. Model Bias and Drift from Fragmented Longitudinal Data

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Software held 72.48% share in 2025, which means the buying center of AI in population health management market is still concentrated around durable platforms rather than short-term consulting work. This pattern fits a platform-first procurement model because providers and payers want one operating environment that can support risk identification, outreach, contract analytics, and utilization management together. The AI in the population health management market has therefore favored vendors that can embed AI directly into software modules rather than leaving intelligence outside the core application stack. That dynamic reduces the role of episodic advisory work at the earliest stage of adoption, since the initial value now depends more on what the installed platform can do every day.

Services are still the fastest-growing component at 22.97% CAGR over 2026-2031, which shows that implementation work remains important even when software owns the larger revenue base. Growth in services comes from managed support, deployment expertise, and change management for organizations that do not have internal data science or integration teams. The AI in population health management market still carries meaningful service demand because legacy EHR environments, fragmented claims feeds, and provider workflow differences make deployment harder than software demonstrations often suggest. Compliance expectations around predictive decision-support interventions also expand the need for documentation, validation, and governance support across live installations. Within the AI in population health management industry, that leaves the component mix looking stable at the top line, but more service intensive below the surface as buyers move from pilot use into scaled operations.

Cloud-based deployment held 56.27% share in 2025, which confirms that the AI in population health management market still relies heavily on scalable environments that can handle multi-source ingestion and near real-time analytics. Cloud adoption fits population health workloads because those workloads depend on continuous data refresh, broad interoperability, and frequent model updates across large attributed populations. The model also supports faster expansion across use cases because organizations can add risk scoring, care-gap logic, and engagement tools without rebuilding the entire data foundation. In practical terms, cloud remains the easiest path for many buyers who need to combine payer data, provider data, pharmacy data, and outreach activity in one view. That is why the current revenue base in the AI in population health management market continues to lean toward cloud, even as privacy and sovereignty debates become more visible.

On-premises deployment is the fastest-growing mode at 23.56% CAGR over 2026-2031, which shows that data control is becoming a more important buying factor in regulated settings. The AI in population health management market size for on-premises and tightly controlled local environments is rising where buyers want stronger oversight of model training, sensitive patient records, and data movement across borders. China's NHSA stated in 2026 that AI models for the Personal Medical Insurance Cloud should train internally without data leaving the platform, which illustrates why sovereign or tightly bounded architectures are gaining support. The AI in population health management market is therefore not moving toward one universal hosting model, because many organizations now want cloud flexibility and local control at the same time. Hybrid deployment has become the practical compromise for many mid-market health systems that want the economics of cloud while still meeting residency and privacy expectations.

Complete Report Scope:

• By Component
  • Software
  • Services
• By Deployment Mode
  • Cloud-Based
  • On-Premises
  • Hybrid
• By Application
  • Population Health Analytics
  • Patient Engagement
  • Risk Stratification
  • Care Management & Coordination
  • Financial & Network Performance Analytics
  • Others
• By End User
  • Healthcare Providers
  • Healthcare Payers
  • Accountable Care Organizations
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 38.47% of AI in population health management market share in 2025, which keeps the region at the center of current commercial activity. The United States remains the main proving ground because TEAM, ACO REACH, and the Ambulatory Specialty Model place value-based accountability and performance measurement at the center of care financing. That policy stack gives the AI in population health management market a stronger demand signal than in most other regions, since providers and payers have clearer reasons to track cost, quality, utilization, and attributed outcomes in one system. North America also benefits from mature payer-provider contracting structures and a broad installed EHR infrastructure, which makes population-level analytics easier to operationalize. These conditions keep the AI in population health management market commercially strongest in North America, even as growth begins to broaden more sharply outside the region.

Europe is more fragmented, but the region is becoming more organized as data governance, AI oversight, and secondary data access rules move into a clearer framework. Germany's opt-out electronic patient file covered all 73 million statutory insured people from January 2025 and began feeding the national Research Data Center from July 2025 under formal oversight, which gives the region a stronger longitudinal data base than before. France committed EUR 110 million, around USD 119 million, through France 2030 for health data warehouses and launched a national AI and health data strategy in July 2025 focused on population-level monitoring and digital twin modeling. The UK's NHS reform agenda is also pushing faster AI use in primary care, especially where capacity pressure and missed appointments are already affecting access. At the same time, European medical leadership has warned that slow validation and governance processes could leave scale advantages to U.S. and Chinese technology firms, which explains why procurement intent is rising even where deployment still lags.

Asia-Pacific is the fastest-growing region, with AI in population health management market size in the region projected to expand at 24.93% CAGR over 2026-2031. China is the clearest scale story inside that growth, because the 15th Five-Year Plan for 2026-2030 treats AI healthcare as a strategic priority, and domestic releases had reached nearly 300 medical large models by May 2025 while county-level remote imaging services had already handled more than 68 million cases. China's NHSA also launched the Personal Medical Insurance Cloud pilot in February 2026 to build dynamic health profiles across the full care lifecycle for 1.33 billion insured people. The AI in population health management market is therefore likely to find some of its longest runway in Asia-Pacific, where public system modernization, chronic disease pressure, and national-scale data platforms can all support broader deployment over time.

1. Arcadia Solutions, LLC
2. Athenahealth
3. Cedar Gate Technologies, LLC
4. Clarify Health Solutions, Inc.
5. Cotiviti, Inc.
6. eClinicalWorks
7. Epic Systems
8. Health Catalyst, Inc.
9. HealthEC, LLC
10. Innovaccer
11. Koninklijke Philips
12. Lightbeam Health Solutions, Inc.
13. Lumeris, Inc.
14. Medecision, Inc.
15. Milliman MedInsight, Inc.
16. NextGen Healthcare
17. Optum
18. Oracle Health, Inc.
19. Persivia Inc.
20. ZeOmega Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Shift Toward Value-Based Reimbursement
  • 4.2.2 Rising Chronic-Disease Burden
  • 4.2.3 AI-Driven Risk Stratification and Care-Gap Closure
  • 4.2.4 Cloud-Native Healthcare Data Platforms
  • 4.2.5 Medicaid and Public-Health Data Modernization
  • 4.2.6 Primary-Care Workforce Shortages Favor Panel Automation
• 4.3 Market Restraints
  • 4.3.1 Data Privacy and Cybersecurity Risks
  • 4.3.2 High Implementation and Legacy Integration Costs
  • 4.3.3 Unclear AI Reimbursement and Liability Frameworks
  • 4.3.4 Model Bias and Drift from Fragmented Longitudinal Data
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Component
  • 5.1.1 Software
  • 5.1.2 Services
• 5.2 By Deployment Mode
  • 5.2.1 Cloud-Based
  • 5.2.2 On-Premises
  • 5.2.3 Hybrid
• 5.3 By Application
  • 5.3.1 Population Health Analytics
  • 5.3.2 Patient Engagement
  • 5.3.3 Risk Stratification
  • 5.3.4 Care Management & Coordination
  • 5.3.5 Financial & Network Performance Analytics
  • 5.3.6 Others
• 5.4 By End User
  • 5.4.1 Healthcare Providers
  • 5.4.2 Healthcare Payers
  • 5.4.3 Accountable Care Organizations
  • 5.4.4 Others
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level overview, Core Segments, Financials as Available, Strategic Information, Market Rank/Share for Key Companies, Products & Services, and Recent Developments)
  • 6.3.1 Arcadia Solutions, LLC
  • 6.3.2 athenahealth, Inc.
  • 6.3.3 Cedar Gate Technologies, LLC
  • 6.3.4 Clarify Health Solutions, Inc.
  • 6.3.5 Cotiviti, Inc.
  • 6.3.6 eClinicalWorks, LLC
  • 6.3.7 Epic Systems Corporation
  • 6.3.8 Health Catalyst, Inc.
  • 6.3.9 HealthEC, LLC
  • 6.3.10 Innovaccer Inc.
  • 6.3.11 Koninklijke Philips N.V.
  • 6.3.12 Lightbeam Health Solutions, Inc.
  • 6.3.13 Lumeris, Inc.
  • 6.3.14 Medecision, Inc.
  • 6.3.15 Milliman MedInsight, Inc.
  • 6.3.16 NextGen Healthcare, Inc.
  • 6.3.17 Optum, Inc.
  • 6.3.18 Oracle Health, Inc.
  • 6.3.19 Persivia Inc.
  • 6.3.20 ZeOmega Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & unmet-need assessment